BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7940894)

  • 1. Interactions of cyclosporine and some derivatives with model membranes: binding and ion permeability changes.
    Fahr A; Nimmerfall F; Wenger R
    Transplant Proc; 1994 Oct; 26(5):2837-41. PubMed ID: 7940894
    [No Abstract]   [Full Text] [Related]  

  • 2. A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A.
    Liu Y; Jiang J; Richardson PL; Reddy RD; Johnson DD; Kati WM
    Anal Biochem; 2006 Sep; 356(1):100-7. PubMed ID: 16737676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo.
    Trammer B; Amann A; Haltner-Ukomadu E; Tillmanns S; Keller M; Högger P
    Eur J Pharm Biopharm; 2008 Nov; 70(3):758-64. PubMed ID: 18656538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of the cyclosporin A/cyclophilin complex by NMR.
    Thériault Y; Logan TM; Meadows R; Yu L; Olejniczak ET; Holzman TF; Simmer RL; Fesik SW
    Nature; 1993 Jan; 361(6407):88-91. PubMed ID: 8421500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of anions on valinomycin-induced permeability of liposomes].
    Barsukov LI; Shkrob AM; Bergel'son LD
    Biofizika; 1972; 17(6):1032-6. PubMed ID: 4643712
    [No Abstract]   [Full Text] [Related]  

  • 6. Modeling conformational changes in cyclosporin A.
    O'Donohue MF; Burgess AW; Walkinshaw MD; Treutlein HR
    Protein Sci; 1995 Oct; 4(10):2191-202. PubMed ID: 8535256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis of cyclosporin A: identification of 1,11 seco-cyclosporin A and 4,5 seco-isocyclosporin A by FAB-MS/MS.
    Magni F; Arnoldi L; Del Puppo M; Galli Kienle M
    Peptides; 1995; 16(8):1335-41. PubMed ID: 8745041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular replacement solution and X-ray refinement to 2.8 A of a decameric complex of human cyclophilin A with the immunosuppressive drug cyclosporin A.
    Pflügl GM; Kallen J; Jansonius JN; Walkinshaw MD
    J Mol Biol; 1994 Dec; 244(4):385-409. PubMed ID: 7990129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of sterols on melittin incorporation into liposomal membranes].
    Adamian SIa; Kaulin IuA; Kuznetsova IM; Turoverov KK; Shchagina LV
    Tsitologiia; 1998; 40(8-9):801-5. PubMed ID: 9821252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological conversion of a water-soluble prodrug of cyclosporine A.
    Lallemand F; Varesio E; Felt-Baeyens O; Bossy L; Hopfgartner G; Gurny R
    Eur J Pharm Biopharm; 2007 Sep; 67(2):555-61. PubMed ID: 17475453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine: intrinsic binding energies to interpret structure-activity relationships.
    Wenger RM; Payne T
    Prog Clin Biol Res; 1989; 291():301-5. PubMed ID: 2726862
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics and mechanism of isomerization of cyclosporin A.
    Oliyai R; Stella VJ
    Pharm Res; 1992 May; 9(5):617-22. PubMed ID: 1608891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiolipin regulates the activity of the reconstituted mitochondrial calcium uniporter by modifying the structure of the liposome bilayer.
    Zazueta C; Ramírez J; García N; Baeza I
    J Membr Biol; 2003 Jan; 191(2):113-22. PubMed ID: 12533778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes.
    Dathe M; Schümann M; Wieprecht T; Winkler A; Beyermann M; Krause E; Matsuzaki K; Murase O; Bienert M
    Biochemistry; 1996 Sep; 35(38):12612-22. PubMed ID: 8823199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?
    Fricker G; Fahr A
    Yale J Biol Med; 1997; 70(4):379-90. PubMed ID: 9626758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobility and molecular orientation of vitamin E in liposomal membranes as determined by 19F NMR and fluorescence polarization techniques.
    Urano S; Matsuo M; Sakanaka T; Uemura I; Koyama M; Kumadaki I; Fukuzawa K
    Arch Biochem Biophys; 1993 May; 303(1):10-4. PubMed ID: 8489254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformations and orientations of aromatic amino acid residues of tachyplesin I in phospholipid membranes.
    Oishi O; Yamashita S; Nishimoto E; Lee S; Sugihara G; Ohno M
    Biochemistry; 1997 Apr; 36(14):4352-9. PubMed ID: 9100032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancers.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):870-3. PubMed ID: 16182296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine: an immunologic breakthrough.
    Dipalma JR
    Am Fam Physician; 1987 Sep; 36(3):245-7. PubMed ID: 3630887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.